Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation
- PMID: 18446476
- PMCID: PMC2976896
- DOI: 10.1208/s12249-007-9028-2
Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation
Abstract
The purpose of this study was to prepare lipospheres containing aceclofenac intended for topical skin delivery with the aim of exploiting the favorable properties of this carrier system and developing a sustained release formula to overcome the side effects resulting from aceclofenac oral administration. Lipospheres were prepared using different lipid cores and phospholipid coats adopting melt and solvent techniques. Characterization was carried out through photomicroscopy, scanning electron microscopy, particle size analysis, DSC, In vitro drug release and storage study. The anti-inflammatory effect of liposphere systems was assessed by the rat paw edema technique and compared to the marketed product. Results revealed that liposphere systems were able to entrap aceclofenac at very high levels (93.1%). The particle size of liposphere systems was well suited for topical drug delivery. DSC revealed the molecular dispersion of aceclofenac when incorporated in lipospheres. Both entrapment efficiency and release were affected by the technique of preparation, core and coat types, core to coat ratio and drug loading. Lipospheres were very stable after 3 months storage at 2-8 degrees C manifested by low leakage rate (less than 7%) and no major changes in particle size. Finally, liposphere systems were found to possess superior anti-inflammatory activity compared to the marketed product in both lotion and paste consistencies. Liposphere systems proved to be a promising topical system for the delivery of aceclofenac as they possessed the ability to entrap the drug at very high levels and high stability, and to sustain the anti-inflammatory effect of the drug.
Figures




Similar articles
-
Vesicular aceclofenac systems: a comparative study between liposomes and niosomes.J Microencapsul. 2008 Oct;25(7):499-512. doi: 10.1080/02652040802055411. J Microencapsul. 2008. PMID: 18608811
-
Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.Curr Drug Deliv. 2013 Dec;10(6):656-66. doi: 10.2174/156720181006131125150023. Curr Drug Deliv. 2013. PMID: 24274634
-
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.Drug Deliv. 2016 Oct;23(8):3135-3145. doi: 10.3109/10717544.2016.1155244. Epub 2016 Mar 10. Drug Deliv. 2016. PMID: 26960815
-
Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds.Chem Phys Lipids. 2012 May;165(4):438-53. doi: 10.1016/j.chemphyslip.2012.01.007. Epub 2012 Feb 9. Chem Phys Lipids. 2012. PMID: 22342324 Review.
-
Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.Biomed Res Int. 2014;2014:406731. doi: 10.1155/2014/406731. Epub 2014 Jun 18. Biomed Res Int. 2014. PMID: 25045671 Free PMC article. Review.
Cited by
-
Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment.Pharmaceuticals (Basel). 2022 Aug 30;15(9):1083. doi: 10.3390/ph15091083. Pharmaceuticals (Basel). 2022. PMID: 36145303 Free PMC article.
-
Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation.Sci Pharm. 2012 Jul-Sep;80(3):749-64. doi: 10.3797/scipharm.1202-12. Epub 2012 Jun 18. Sci Pharm. 2012. PMID: 23008819 Free PMC article.
-
Freeze-drying of bupivacaine lipospheres: preparation, characterization, and evaluation of anti-microbial properties.Daru. 2024 Jun;32(1):207-214. doi: 10.1007/s40199-024-00506-1. Epub 2024 Feb 29. Daru. 2024. PMID: 38421501 Free PMC article.
-
Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution.J Young Pharm. 2012 Oct;4(4):209-19. doi: 10.4103/0975-1483.104364. J Young Pharm. 2012. PMID: 23493109 Free PMC article.
-
Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octocrylene: effect on photostability.AAPS PharmSciTech. 2009;10(2):384-90. doi: 10.1208/s12249-009-9217-2. Epub 2009 Apr 21. AAPS PharmSciTech. 2009. PMID: 19381836 Free PMC article.
References
-
- Valjakka-Koskela R., Kirjavainen M., Monkkonen J., Urtti A., Kiesvaara J. Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. 1998;175:225–230. doi: 10.1016/S0378-5173(98)00285-3. - DOI
-
- Domb A.J., Bergelson L., Amselem S., Benita S. Microencapsulation, methods and industrial applications. New York, NY: Marcel Dekker; 1996. Lipospheres for controlled delivery of substances; pp. 377–410.
-
- Insel P.A. Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman L.S., Gilman A., Rall T.W., Nies A.S., Taylor P., editors. The pharmacological basis of therapeutics. New York, NY: McGraw-Hill International editions; 1992. pp. 638–681.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources